Data / Drug companies / Verityrx, LLC
Verityrx, LLC: 17 products in the FDA NDC directory, labeler code 83939
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Verityrx, LLC (labeler code 83939) lists 17 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 9 prescription drugs, 8 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 3, 2025.
The request: Watch Verityrx, LLC (FDA labeler code 83939): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83939
- Products in commercial distribution
- 17
- Packages
- 61
- Finished drugs by generic name
- 13
- Prescription products
- 9
- Over the counter products
- 8
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- August 26, 2009
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 11 | 64.7% |
| Over the counter monograph drugs | 5 | 29.4% |
| Other unapproved drugs | 1 | 5.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 9 | 52.9% |
| Over the counter drugs | 8 | 47.1% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 5 | 29.4% |
| Tablet, film coated | 4 | 23.5% |
| Liquid | 4 | 23.5% |
| Capsule | 2 | 11.8% |
| Tablet, coated | 1 | 5.9% |
| Solution | 1 | 5.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Cetirizine | 83939-0003 | Tablet, film coated | Generic drugs (ANDA) | November 3, 2025 |
| Ciprofloxacin Hydrochloride | 83939-0002 | Tablet, film coated | Generic drugs (ANDA) | May 23, 2024 |
| M-pap | 83939-0011 | Liquid | Over the counter monograph drugs | April 1, 2024 |
| Nitrofurantoin macrocrystals | 83939-0016 | Capsule | Generic drugs (ANDA) | March 21, 2023 |
| Clonidine hydrochloride | 83939-0006 | Tablet | Generic drugs (ANDA) | December 24, 2020 |
| Geri-Dryl allergy relief | 83939-0683 | Tablet, coated | Over the counter monograph drugs | April 1, 2020 |
| Children Acetaminophen Oral Solution | 83939-0010 | Liquid | Over the counter monograph drugs | October 1, 2019 |
| Geri Dryl | 83939-0007 | Liquid | Over the counter monograph drugs | October 1, 2019 |
| M-Dryl | 83939-0008 | Liquid | Over the counter monograph drugs | August 1, 2019 |
| Cetirizine Hydrochloride | 83939-0004 | Tablet, film coated | Generic drugs (ANDA) | December 17, 2018 |
| Oxybutynin Chloride | 83939-0022 | Tablet | Generic drugs (ANDA) | November 15, 2017 |
| Clonidine hydrochloride | 83939-0005 | Tablet | Generic drugs (ANDA) | May 3, 2016 |
| Levofloxacin | 83939-0020 | Tablet, film coated | Generic drugs (ANDA) | January 9, 2015 |
| Childrens Cetirizine Hydrochloride Sugar Free Grape | 83939-0009 | Solution | Generic drugs (ANDA) | September 8, 2011 |
| Phenazopyridine Hydrochloride | 83939-0021 | Tablet | Other unapproved drugs | February 1, 2011 |
| Sulfamethoxazole and Trimethoprim | 83939-0023 | Tablet | Generic drugs (ANDA) | February 16, 2010 |
| Clindamycin Hydrochloride | 83939-0019 | Capsule | Generic drugs (ANDA) | August 26, 2009 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.